Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

272.16 USD -1.68 (-0.61%)
Streaming Delayed Price Updated: 11:45 AM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Benzinga's Top Upgrades, Downgrades For November 9, 2020
Upgrades According to UBS, the prior rating for Yelp Inc (NYSE: YELP) was changed from Sell to Neutral. Yelp earned $0.01 in the ... 
Tags CHRW ARRY Benzinga
From Benzinga
Biogen Stock Crashes After FDA Panel Rejects Alzheimer's Treatment
Biogen stock crashed Monday after a Food and Drug Administration panel voted against recommending its controversial Alzheimer's treatment for approval. Shares were down more than 30% early. 
From Investor's Business Daily
Dow Jones Today, Stock Futures Spike 1,500 Points On Biden Presidency, Pfizer Vaccine News
The Dow Jones today soared more than 1,500 points, Pfizer and BioNTech spiked on coronvirus vaccine news as markets valued in a Joe Biden presidency. 
From Investor's Business Daily
Analysts Predict Volatility In Biogen Shares Until March 2021
Wall Street analysts suggest thatBiogen Inc(NASDAQ:BIIB) stock is about to see a significant selloff and could witness ... 
Tags Benzinga Market News alzheimer's treatment
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags HSDT RVNC DYAI
From Benzinga
Barron's Picks And Pans: Apollo Global, Biogen, Biden Picks And More
This weekend's Barron's examines how Biden won an extraordinary electionand what a Biden administration could ... 
Tags Market News Biogen Pfizer
From Benzinga
Biogen's Aducanumab Fails To Win FDA Panel Backing
Biogen Inc. failed to win the backing of the FDA panel which reviewed the BLA for its controversial Alzheimer's drug aducanumab, an antibody which targets amyloid-beta. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Stock Market Rally Analysis; Alibaba, Nvidia In Buy Range; Biogen, Nio, Tesla, Xpeng, Li Auto In Focus
Last week's market rally showed real power. Biogen is in focus after a FDA panel panned its Alzheimer's drug. China EV sales are due for Tesla and Nio. 
From Investor's Business Daily
Biogen's Aducanumab Fails To Win FDA Panel Backing
Biogen Inc (NASDAQ: BIIB) failed to win the backing of the FDA panel which reviewed the BLA for its controversial Alzheimer's drug ... 
Tags FDA Top Stories News
From Benzinga
Biogen Stock Halted As FDA Panel Prepares To Discuss Alzheimer's Drug
Biogen stock was halted early Friday ahead of a Food and Drug Administration advisory committee meeting to discuss the fate of its controversial Alzheimer's treatment, aducanumab. 
From Investor's Business Daily
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PODD EYEG Benzinga
From Benzinga
Lam Research Now #115 Largest Company, Surpassing Biogen
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Lam Research Corp (LRCX) has taken over the #115 spot from Biogen Inc (BIIB), according to The... 
Tags Stocks
From Market News Video
Biogen Analysts Brace For Favorable Aducanumab Adcom Verdict
Biogen Inc (NASDAQ: BIIB) shares saw a nice 40% bumpWednesday following the release of FDA briefing document prepared for ... 
Tags Market News Reiteration Benzinga
From Benzinga
Thursday's ETF Movers: TAN, FBT
In trading on Thursday, the Invesco Solar ETF is outperforming other ETFs, up about 10.9% on the day. Components of that ETF showing particular strength include shares of Jinkosolar Holding, up about... 
Tags ETFs
From ETF Channel
Investors Cheer Gridlock Potential That Could Prevent Tax, Tech, Health Care Overhauls
It’s often been said that the stock market dislikes uncertainty. So it may be a little bit of a surprise that the market rally is ... 
Tags BIIB Facebook UNH
From Benzinga
Signs point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skeptics
Odds are increasing that Biogen’s experimental and somewhat controversial Alzheimer’s disease drug may get approved after Food and Drug Administration officials said there was enough evidence in... 
Tags LLY Commodities SPX
From MarketWatch
Benzinga's Top Upgrades, Downgrades For November 5, 2020
Upgrades According to DA Davidson, the prior rating for Medifast Inc (NYSE: MED) was changed from Neutral to Buy. Medifast earned ... 
Tags FSLR top upgrades Downgrades
From Benzinga
Nasdaq 100 Movers: BIIB, QCOM
In early trading on Thursday, shares of Qualcomm topped the list of the day's best performing components of the Nasdaq 100 index, trading up 14.2%. Year to date, Qualcomm registers a 67.0% gain. 
Tags Stocks
From Market News Video
Return On Capital Employed Overview: Biogen
Biogen (NASDAQ: BIIB) posted Q3 earnings of $1.13 billion, an increase from Q2 of 43.66%. Sales dropped to $3.38 billion, a 8.31% ... 
Tags Earnings BIIB Market News
From Benzinga
10 Biggest Price Target Changes For Thursday
Needham raised the price target for Cardiovascular Systems Inc (NASDAQ: CSII) from $44 to $47. Cardiovascular Systems shares fell ... 
Tags Pre/Market Outlook Price Target Changes CSII
From Benzinga
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FDA TBPH ATRC
From Benzinga
Tech And Healthcare Stocks Are The Big Winners As Biden One State From Victory
Stock markets globally gained yesterday as Democratic nominee Joe Biden neared victory in the US presidential election. Overnight, Asian markets were firmer, with the Japanese Nikkei and Hong Kong’s... 
Tags Pharma/Biotech Conglomerates Consumer Goods
From Blogs - TalkMarkets
51 Biggest Movers From Yesterday
Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 51.2% to close at $16.98 on Wednesday. Aptevo Therapeutics, on ... 
Tags BIIB ACIU GEO
From Benzinga
These stocks rose the most Wednesday as investors cheered a divided government following the elections
The Nasdaq Composite Index jumped 3.9%, led by tech and health-care stocks. 
Tags VZ FB Services/Consulting
From MarketWatch
Option Trader Bets $2.5M On Biogen After FDA's Favorable Alzheimer's Drug Support
Biogen Inc (NASDAQ: BIIB) shares jumped more than 40% on Wednesday after the company received a favorable FDA briefing related to the ... 
Tags BIIB Bank of America Markets
From Benzinga
Why Eli Lilly's Stock Is Trading Higher Today
Eli Lilly (NYSE: LLY) shares are trading higher on Wednesday. The strength is potentially in sympathy with Biogen(NASDAQ: BIIB) ... 
Tags BIIB LLY Market News
From Benzinga
Mid-Afternoon Market Update: Dow Jumps 600 Points; Super Micro Computer Shares Climb On Upbeat Earnings
Toward the end of trading Wednesday, the Dow traded up 2.21% to 28,087.29 while the NASDAQ rose 3.83% to 11,588.19. The S&P also ... 
Tags News Earnings Markets
From Benzinga
Wednesday's ETF Movers: FBT, KRE
In trading on Wednesday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 6.4% on the day. Components of that ETF showing particular strength include shares... 
Tags ETFs
From ETF Channel
12 Healthcare Stocks Moving In Wednesday's Intraday Session
Gainers Biogen (NASDAQ:BIIB) stock increased by 40.06% to $345.96 during Wednesday's regular session. As of 12:31 ... 
Tags SUPN CMPI ATHA
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Biogen Inc. (NASDAQ: BIIB) shares jumped 40.6% to $347.39 after FDA briefing documents showed company provided evidence of ... 
Tags ANDE Mid/Day Movers Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.